Int. J. Mol. Sci. 2013, 14(1), 935-953; doi:10.3390/ijms14010935
Article

Ochratoxin A Inhibits Mouse Embryonic Development by Activating a Mitochondrion-Dependent Apoptotic Signaling Pathway

1 Department of Life Science, National Pingtung University of Science and Technology, Pingtung 912, Taiwan 2 Department of Bioscience Technology and Center for Nanotechnology, Chung Yuan Christian University, Chung Li 320, Taiwan 3 Department of Cell and Molecular Biology, Institute of Biomedical Sciences, Medical College of Chang Gung University, Tao-Yuan 333, Taiwan
* Author to whom correspondence should be addressed.
Received: 22 October 2012; in revised form: 10 December 2012 / Accepted: 24 December 2012 / Published: 7 January 2013
(This article belongs to the Special Issue Signalling Molecules and Signal Transduction in Cells)
PDF Full-text Download PDF Full-Text [611 KB, uploaded 7 January 2013 09:03 CET]
Abstract: Ochratoxin A (OTA), a mycotoxin found in many foods worldwide, causes nephrotoxicity, hepatotoxicity, and immunotoxicity, both in vitro and in vivo. In the present study, we explored the cytotoxic effects exerted by OTA on the blastocyst stage of mouse embryos, on subsequent embryonic attachment, on outgrowth in vitro, and following in vivo implantation via embryo transfer. Mouse blastocysts were incubated with or without OTA (1, 5, or 10 μM) for 24 h. Cell proliferation and growth were investigated using dual differential staining; apoptosis was measured using the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay; and embryo implantation and post-implantation development were assessed by examination of in vitro growth and the outcome of in vivo embryo transfer, respectively. Blastocysts treated with 10 μM OTA displayed a significantly increased level of apoptosis and a reduction in total cell number. Interestingly, we observed no marked difference in implantation success rate between OTA-pretreated and control blastocysts either during in vitro embryonic development (following implantation in a fibronectin-coated culture dish) or after in vivo embryo transfer. However, in vitro treatment with 10 μM OTA was associated with increased resorption of post-implantation embryos by the mouse uterus, and decreased fetal weight upon embryo transfer. Our results collectively indicate that in vitro exposure to OTA triggers apoptosis and retards early post-implantation development after transfer of embryos to host mice. In addition, OTA induces apoptosis-mediated injury of mouse blastocysts, via reactive oxygen species (ROS) generation, and promotes mitochondrion-dependent apoptotic signaling processes that impair subsequent embryonic development.
Keywords: ochratoxin A; blastocyst; apoptosis; development; ROS

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Hsuuw, Y.-D.; Chan, W.-H.; Yu, J.-S. Ochratoxin A Inhibits Mouse Embryonic Development by Activating a Mitochondrion-Dependent Apoptotic Signaling Pathway. Int. J. Mol. Sci. 2013, 14, 935-953.

AMA Style

Hsuuw Y-D, Chan W-H, Yu J-S. Ochratoxin A Inhibits Mouse Embryonic Development by Activating a Mitochondrion-Dependent Apoptotic Signaling Pathway. International Journal of Molecular Sciences. 2013; 14(1):935-953.

Chicago/Turabian Style

Hsuuw, Yan-Der; Chan, Wen-Hsiung; Yu, Jau-Song. 2013. "Ochratoxin A Inhibits Mouse Embryonic Development by Activating a Mitochondrion-Dependent Apoptotic Signaling Pathway." Int. J. Mol. Sci. 14, no. 1: 935-953.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert